Bogucka K - Search Results

1

Circulating Angiogenic Factors and Ischemic Diabetic Foot Syndrome Advancement-A Pilot Study.

Schönborn M, Gregorczyk-Maga I, Batko K, Bogucka K, Maga M, Płotek A, Pasieka P, Słowińska-Solnica K, Maga P. Schönborn M, et al. Among authors: bogucka k. Biomedicines. 2023 May 27;11(6):1559. doi: 10.3390/biomedicines11061559. Biomedicines. 2023. PMID: 37371653 Free PMC article.

2

Angiogenic and Microvascular Status Alterations after Endovascular Revascularization of Lower Limb Arteries among Patients with Diabetic Foot Syndrome: A Prospective 12-Month Follow-Up Study.

Schönborn M, Gregorczyk-Maga I, Batko K, Maga M, Bogucka K, Gawlik K, Pawlica-Gosiewska D, Maga P. Schönborn M, et al. Among authors: bogucka k. J Clin Med. 2023 Aug 27;12(17):5581. doi: 10.3390/jcm12175581. J Clin Med. 2023. PMID: 37685648 Free PMC article.

3

Increased Levels of (p)ppGpp Correlate with Virulence and Biofilm Formation, but Not with Growth, in Strains of Uropathogenic Escherichia coli.

Karczewska M, Strzelecki P, Bogucka K, Potrykus K, Szalewska-Pałasz A, Nowicki D. Karczewska M, et al. Among authors: bogucka k. Int J Mol Sci. 2023 Feb 7;24(4):3315. doi: 10.3390/ijms24043315. Int J Mol Sci. 2023. PMID: 36834725 Free PMC article.

4

Recent advances in targeting protein kinases and pseudokinases in cancer biology.

Riegel K, Vijayarangakannan P, Kechagioglou P, Bogucka K, Rajalingam K. Riegel K, et al. Among authors: bogucka k. Front Cell Dev Biol. 2022 Jul 22;10:942500. doi: 10.3389/fcell.2022.942500. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35938171 Free PMC article. Review.

5

XDR-TB Transmitted from Mother to 10-Month-Old Infant: Diagnostic and Therapeutic Problems.

Kozińska M, Bogucka K, Kędziora K, Szpak-Szpakowska J, Pędzierska-Olizarowicz W, Pustkowski A, Augustynowicz-Kopeć E. Kozińska M, et al. Among authors: bogucka k. Diagnostics (Basel). 2022 Feb 8;12(2):438. doi: 10.3390/diagnostics12020438. Diagnostics (Basel). 2022. PMID: 35204528 Free PMC article.

6

Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.

Bogucka K, Marini F, Rosigkeit S, Schloeder J, Jonuleit H, David K, Schlackow M, Rajalingam K. Bogucka K, et al. Cancer Gene Ther. 2021 May;28(5):543. doi: 10.1038/s41417-020-00250-z. Cancer Gene Ther. 2021. PMID: 33168935 No abstract available.

7

ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.

Bogucka K, Marini F, Rosigkeit S, Schloeder J, Jonuleit H, David K, Schlackow M, Rajalingam K. Bogucka K, et al. Cancer Gene Ther. 2021 May;28(5):359-374. doi: 10.1038/s41417-020-00245-w. Epub 2020 Oct 17. Cancer Gene Ther. 2021. PMID: 33070159

8

ERK3/MAPK6 controls IL-8 production and chemotaxis.

Bogucka K, Pompaiah M, Marini F, Binder H, Harms G, Kaulich M, Klein M, Michel C, Radsak MP, Rosigkeit S, Grimminger P, Schild H, Rajalingam K. Bogucka K, et al. Elife. 2020 Apr 21;9:e52511. doi: 10.7554/eLife.52511. Elife. 2020. PMID: 32314963 Free PMC article.

9

Various modes of action of dietary phytochemicals, sulforaphane and phenethyl isothiocyanate, on pathogenic bacteria.

Nowicki D, Maciąg-Dorszyńska M, Bogucka K, Szalewska-Pałasz A, Herman-Antosiewicz A. Nowicki D, et al. Among authors: bogucka k. Sci Rep. 2019 Sep 23;9(1):13677. doi: 10.1038/s41598-019-50216-x. Sci Rep. 2019. PMID: 31548597 Free PMC article.

10

Antibacterial and anticancer activities of acetone extracts from in vitro cultured lichen-forming fungi.

Felczykowska A, Pastuszak-Skrzypczak A, Pawlik A, Bogucka K, Herman-Antosiewicz A, Guzow-Krzemińska B. Felczykowska A, et al. Among authors: bogucka k. BMC Complement Altern Med. 2017 Jun 7;17(1):300. doi: 10.1186/s12906-017-1819-8. BMC Complement Altern Med. 2017. PMID: 28592323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page